The biotech CytoDyn (OTCQB:CYDY) installed Cyrus Arman as president starting on July 9, 2022. Arman will assume the CEO role and join the company’s board within six months.  Before joining CytoDyn, Arman was the chief business officer at Nimble Therapeutics (Madison, Wisconsin), assuming that role on ​​September 08, 2021.  “Early in the process, Dr. Arman…